2025
article
OpenAlex
Lianyuan Yu, Lejian He, Nan Zhang
Background: BCOR mutations occur in about 5% in pediatric rhabdomyosarcoma (RMS), their clinical significance and mechanistic roles remain undefined. This study characterizes BCOR-mutant RMS as a molecularly distinct, high-risk subgroup. Methods: Multimodal analysis of four pediatric embryonal RMS cases with BCOR mutations, …
cn
(code pays fourni par la source)
2025
other
OpenAlex
Mingli Zhang, Xingfeng Yao, Ning Zhang, Congwei Jia et autres
DICER1 mutations are frequently detected in pediatric PPB, CN, SCST, ASK, nodular thyroid goiter, thyroid adenoma, and genitourinary rhabdomyosarcoma, which often represent as the index case of DICER1 syndrome. Performing DICER1 mutation testing in these patients not only facilitates tumor diagnosis and …
cn
(code pays fourni par la source)
2025
article
OpenAlex
Ying Fang, Lejian He, Ling Chen
Pediatric tumors differ significantly from adult cancers, possessing unique developmental origins, histological features, and molecular genetic changes. With the rapid advancement of multi-omics technologies, such as genomics, transcriptomics, proteomics, and epigenetic analyses, the molecular characteristics of pediatric tumors have been extensively revealed, …
cn
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Wen Zhao, Zhen Huang, Weiling Zhang, Qing Sun et autres
Background: Ewing's sarcoma family of tumors (ESFTs) comprises a group of aggressive malignancies predominantly affecting children and adolescents. This study aimed to evaluate the clinical characteristics, treatment outcomes, and prognostic factors in adolescent patients with ESFTs. Methods: A multicenter, retrospective cohort study …
cn
(code pays fourni par la source)
2025
review
OpenAlex
Haibo Shi, Z Li, Junwu Su, Lejian He et autres
cn
(code pays fourni par la source)
2025
article
OpenAlex
Shudong Zhang, Lejian He, Lin Chen
The latest published WHO Classification of Pediatric Tumors is the first to be independent of the WHO Classification of Tumors in adults, serving as an independent volume that covers the latest advances in clinical characteristics, histopathology, molecular pathology, pathogenesis, and treatment of …
cn
(code pays fourni par la source)
2025
other
OpenAlex
Mingli Zhang, Xingfeng Yao, Ning Zhang, Jianfeng Xu et autres
The study has established a new method for accurate and rapid detection of MYOD1 mutation in rhabdomyosarcoma, particularly suitable for the formalin-fixed and paraffin-embedded samples in clinical settings. MYOD1 mutations more likely occur in spindle cell/sclerosing rhabdomyosarcoma of the head and neck …
cn
(code pays fourni par la source)
2025
article
OpenAlex
Jun Wu, Kun Yang, Jinfan Zhou, Lejian He et autres
cn
(code pays fourni par la source)
2025
article
OpenAlex
Lejian He, Fen Xie, Dandan Wang, Lu Jiang et autres
cn
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Xingfeng Yao, Yutian Zheng, Meng Zhang, Wentao Zheng et autres
Langerhans cell histiocytosis (LCH) is a rare disorder that primarily affects children. Considering the intricate clinical presentation of this disease, the identification of specific biomarkers associated with susceptibility to LCH is essential for timely diagnosis and risk stratification. In this study, we …
cn
(code pays fourni par la source)
2025
conference-abstract
OpenAlex
Xiaoqing Lin, Xiaobo Chen, Lin Zhong, Shuangshuang He et autres
2025
article
OpenAlex
Ning Zhang, Lejian He
In the past decade, governments, including the national, provincial, municipal, and others, have increased their investment in children's health. Pathologists, especially pediatric pathologists, have greatly promoted the development and progress of pediatric pathology in China with the guidance of molecular pathological technology. …
cn
(code pays fourni par la source)